If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Encompass Health (EHC) . This company, which is in the Zacks Medical - Outpatient and Home Healthcare industry, shows potential for another earnings beat. When looking at the last two reports, this rehabilitation hospital operator has recorded a strong streak of surpassing earnings estimates. The company has topped estimates b ...

Encompass Health (EHC) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate. Individual investo ...

Encompass Health Corporation (EHC) has been gaining on growing patient admissions, commendable expansion initiatives and a robust cash position. A solid 2024 business outlook also reinforces investors' confidence in the stock. EHC's Zacks Rank & Price Performance Encompass Health currently carries a Zacks Rank #3 (Hold). The stock has gained 43.4% in the past year compared with the industry's 34.5% growth. The Zacks Medical sector has rallied 13.1% and the S&P 500 composite increased 33.4% in the same time ...

Encompass Health Rehabilitation Hospital of Fort Mill provides essential rehabilitative services that help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain function and independence. Patients receive a minimum of three hours of intensive therapy for five days each week, frequent physician visits and 24-hour nursing care. "The need for inpatient rehabilitative care in the Fort Mill and greater Charlotte area has been growing rapidly" ...

Encompass Health Corporation (EHC) shares have shot up 39.4% in the year-to-date period, outperforming the industry's return of 17.9% and the S&P 500 Index's rise of 18.4%. Growing patient volumes and impressive growth-related initiatives appear to have catalyzed this bullishness. Currently priced at $93.05, the stock is just 1.4% below its 52-week high of $94.38. This proximity underscores investor confidence and market optimism about this healthcare company's prospects. It has the ingredients for further ...

Investors might want to bet on Encompass Health (EHC) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system. In ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. It also includes access to the Zacks Style Scores ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share EHC New York Stock Exchange FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0 ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | |----------------|-------|------------------------------------|-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2024 Second Quarter Earnings Call | | | | | | | | August 6, 2024 | | Supplemental information | | | | | | | | | | | | | | | | | | | | | | | | | | | Forward-looking statements The information contained in this presentation includes certain estimates, projecti ...

Encompass Health Corporation (NYSE:EHC) Q2 2024 Earnings Call August 6, 2024 10:00 AM ET Company Participants Mark Miller - Chief Investor Relations Officer Mark Tarr - President and Chief Executive Officer Doug Coltharp - Executive Vice President and Chief Financial Officer Conference Call Participants Whit Mayo - Leerink Partners A.J. Rice - UBS Andrew Mok - Barclays Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Scott Fidel - Stephens Brian Tanquilut - Jefferies Jared Haase - William B ...